Evidence map›Paper›PMID 35771811›Full record

ArticlePloS one2022

Comprehensive proteomic quantification of bladder stone progression in a cystinuric mouse model using data-independent acquisitions.

Jacob Rose, Nathan Basisty, Tiffany Zee, Cameron Wehrfritz, Neelanjan Bose, Pierre-Yves Desprez, Pankaj Kapahi, Marshall Stoller, Birgit Schilling

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Alzheimer's Disease Risk Factor APOE4 Exerts Dimorphic Effects on Female Bone.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jacob RoseBuck Institute for Research on Aging, Novato, CA, United States of America.
Nathan BasistyBuck Institute for Research on Aging, Novato, CA, United States of America.
Tiffany ZeeBuck Institute for Research on Aging, Novato, CA, United States of America.
Cameron WehrfritzBuck Institute for Research on Aging, Novato, CA, United States of America.
Neelanjan BoseBuck Institute for Research on Aging, Novato, CA, United States of America.
Pierre-Yves DesprezBuck Institute for Research on Aging, Novato, CA, United States of America.
Pankaj KapahiBuck Institute for Research on Aging, Novato, CA, United States of America.
Marshall StollerUniversity of California San Francisco, San Francisco, CA, United States of America.
Birgit SchillingBuck Institute for Research on Aging, Novato, CA, United States of America.ORCID 0000-0001-9907-2749
Buck Institute for Research on Aging · USUniversity of California, San Francisco · US

Funding

Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's diseaseR01AG068288 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI KAPAHI, PANKAJ · 2020 to 2024
$2.6M
TripleTOF 5600 High Resolution Mass SpectrometerS10OD016281 · OD · BUCK INSTITUTE FOR RESEARCH ON AGING · PI GIBSON, BRADFORD WAYNE · 2013 to 2013
$597k
NIA NIH HHS R01 AG068288NIH HHS S10 OD016281
6 · The paper itself

Abstract

Cystinuria is one of various disorders that cause biomineralization in the urinary system, including bladder stone formation in humans. It is most prevalent in children and adolescents and more aggressive in males. There is no cure, and only limited disease management techniques help to solubilize the stones. Recurrence, even after treatment, occurs frequently. Other than a buildup of cystine, little is known about factors involved in the formation, expansion, and recurrence of these stones. This study sought to define the growth of bladder stones, guided by micro-computed tomography imaging, and to profile dynamic stone proteome changes in a cystinuria mouse model. After bladder stones developed in vivo, they were harvested and separated into four developmental stages (sand, small, medium and large stone), based on their size. Data-dependent and data-independent acquisitions allowed deep profiling of stone proteomics. The proteomic signatures and pathways illustrated major changes as the stones grew. Stones initiate from a small nidus, grow outward, and show major enrichment in ribosomal proteins and factors related to coagulation and platelet degranulation, suggesting a major dysregulation in specific pathways that can be targeted for new therapeutic options.

Indexed as

CystinuriaUrinary Bladder CalculiAnimalsCystineMaleMiceProteomicsX-Ray MicrotomographyCystine

Identifiers

PMID35771811
PMCPMC9246204
OpenAlexW4283732900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.